March 24, 2025
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
New from ACHP:
- ACHP Statement on Drug Pricing
- Ending the Allure of Drug Advertising
- ACHP Letter to Dr. Oz on Deregulation in Health Insurance
- ACHP Comments on CMS Marketplace Integrity & Affordability Proposed Rule
- ACHP Statement on CY2026 MA and Part D Rate Notice
- ACHP Statement on Final CY2026 MA and Part D Rule
